Levofloxacina Teva (Levofloxacin)

Levofloxacina Teva, a fluoroquinolone antibiotic, is indicated for several bacterial infections affecting the respiratory, urinary and skin systems.

• Community‑acquired respiratory tract infections: eradicates typical pathogens such as Streptococcus pneumoniae, providing clinical cure in adult patients.
• Acute bacterial sinusitis: reduces sinus inflammation by eliminating causative bacteria, improving nasal drainage and symptom relief.
• Acute exacerbations of chronic bronchitis: targets bacterial overgrowth to shorten illness duration and prevent further lung damage.
• Uncomplicated urinary tract infections: achieves high urinary concentrations to eradicate Escherichia coli and other common uropathogens.
• Skin and soft‑tissue infections: penetrates tissue to treat cellulitis, abscesses and wound infections caused by susceptible bacteria.
• Prostatitis: attains prostatic fluid levels sufficient to treat bacterial prostatitis and relieve associated symptoms.

• Levofloxacin exerts its antibacterial activity by binding to the A‑subunit of bacterial DNA gyrase and the B‑subunit of topoisomerase IV. This inhibition prevents the supercoiling and relaxation of bacterial DNA required for replication and transcription, leading to rapid bacterial cell death. Consequently, levofloxacin displays a concentration‑dependent bactericidal effect across a broad spectrum of pathogens.

Levofloxacina Teva may cause a variety of adverse reactions, ranging from mild to serious.

Common Side Effects

• Nausea: mild stomach upset occurring in many patients.
• Diarrhea: loose stools that are usually self‑limiting.
• Headache: transient cranial discomfort.
• Rash: mild skin erythema or itching.

Serious or Rare Side Effects

• Tendon rupture: sudden tendon pain or swelling, especially in the Achilles.
• QT interval prolongation: cardiac rhythm changes that may lead to arrhythmia.
• Clostridioides difficile infection: severe colitis following disruption of gut flora.
• Severe allergic reaction: anaphylaxis, angioedema or bronchospasm.

When prescribing Levofloxacina Teva, clinicians should observe several precautionary measures to minimize risk.

• Renal function: adjust dose in patients with impaired renal clearance.
• CNS effects: monitor for seizures, confusion or hallucinations, particularly in the elderly.
• Cardiac risk: avoid use in patients with known QT prolongation or concurrent QT‑prolonging drugs.
• Tendon health: discontinue therapy at the first sign of tendon pain, swelling or inflammation.
• Pregnancy and lactation: prescribe only when the benefit clearly outweighs potential fetal or neonatal risk.
• Store at below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Levofloxacina Teva can interact with several medicines; awareness of major and moderate interactions helps ensure safe therapy.

Major Interactions (Avoid)

• Antacids containing aluminum or magnesium: markedly reduce levofloxacin absorption.
• Other fluoroquinolones (e.g., ciprofloxacin): increase risk of tendon toxicity and CNS effects.
• Warfarin: may potentiate anticoagulant effect and raise INR.
• Theophylline: levofloxacin can raise plasma theophylline levels, leading to toxicity.

Moderate Interactions (Monitor Closely)

• NSAIDs (e.g., ibuprofen): may enhance central nervous system stimulation.
• Diabetes medications (insulin, sulfonylureas): levofloxacin can cause hypoglycemia, requiring glucose monitoring.